HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas
Open Access
- 1 February 2005
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 115 (2) , 329-332
- https://doi.org/10.1002/ijc.20872
Abstract
A considerable subset of oropharyngeal squamous cell carcinomas (SCCs) are positive for human papillomavirus (HPV); however, delineating etiologically‐associated HPV infections from SCCs with concurrent HPV infection unrelated to tumorigenesis is challenging. Viral load assessment in biopsy specimens may help facilitate such differentiation. HPV16 viral load and serologic markers were assessed among oral and oropharyngeal cases from a multinational study conducted by the International Agency for Research on Cancer (IARC). HPV16 viral load, measured semiquantitatively by PCR‐enzyme immunoassay, was dichotomized as high or low based on the median optical density value. Serologic antibodies to HPV16 virus‐like particles (VLPs) and to HPV16 E6 and E7 proteins were measured by ELISA. Compared to HPV DNA‐negative cases (n = 852), HPV16 DNA‐positive cases with high viral load (n = 26) were significantly more likely to originate in the oropharynx (odds ratio [OR], 12.0; 95% confidence interval [CI], 5.2–27.5) and, after adjustment for tumor site (AdjOR), have antibodies against HPV16 VLPs (AdjOR, 14.6; 95% CI, 6.0–35.6), E6 (AdjOR, 57.6; 95% CI, 21.4–155.3) and E7 (AdjOR, 25.6; 95% CI, 9.3–70.8). HPV16 DNA‐positive cases with low viral load (n = 27) were more commonly oropharyngeal (OR, 2.7; 95% CI, 1.1–6.2) and seropositive for HPV16 VLPs (AdjOR, 2.7; 95% CI, 1.1–6.9), E6 (AdjOR, 3.0; 95% CI, 0.7–14.0) and E7 (AdjOR, 3.5; 95% CI, 0.7–16.3), compared to HPV DNA‐negative cases; the associations, however, were neither as strong nor as significant as the associations for high viral load. As there appears to be a strong association between HPV16 serologic markers and viral load, in the absence of data on serologic markers, HPV16 viral load may be used to help delineate the subset of HPV16 DNA‐positive oral and oropharyngeal cancers that may be the consequence of HPV infection.Keywords
This publication has 26 references indexed in Scilit:
- Human Papillomavirus Type 16 and TP53 Mutation in Oral CancerCancer Research, 2004
- Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancersInternational Journal of Cancer, 2003
- Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neckInternational Journal of Cancer, 2003
- The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivityThe Journal of Pathology, 2003
- Serum Immunoglobulin G Response to Human Papillomavirus Type 16 Virus‐Like Particles in Human Immunodeficiency Virus (HIV)–Positive and Risk‐Matched HIV‐Negative WomenThe Journal of Infectious Diseases, 2003
- Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancerInternational Journal of Cancer, 2002
- Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle controlOncogene, 2002
- Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearanceInternational Journal of Cancer, 2002
- The Natural History of Human Papillomavirus Type 16 Capsid Antibodies among a Cohort of University WomenThe Journal of Infectious Diseases, 1996
- Evaluation of Seroreactivity to Human Papillomavirus Type 16 Virus-like Particles in an Incident Case-Control Study of Cervical NeoplasiaThe Journal of Infectious Diseases, 1995